Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Allergy Thera. (AGY) Share News

ZQ makes mandatory offer for Allergy Therapeutics as holding hits 60%

16th Oct 2023 08:40

(Alliance News) - ZQ Capital Management Ltd on Monday announced a mandatory takeover offer for Allergy Therapeutics PLC, as required under UK takeover rules, but it said the offer won't be accepted by the Allergy's second largest shareholder and so won't succeed. Read More

IN BRIEF: Allergy Therapeutics raises GBP40.8 million in fundraise

13th Oct 2023 14:07

Allergy Therapeutics PLC - West Sussex, England-based commercial biotechnology company - Says that it has conditionally raised total gross proceeds of approximately GBP40.8 million through an equity financing, which was announced on April 6. Proceeds of the equity financing will be used to repay amounts owed under the loan facility agreement. Read More

EARNINGS: Safestyle suffers amid "difficult" trading conditions

27th Sep 2023 13:10

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

TRADING UPDATES: Cohort trading ahead of expectations, record orders

26th Sep 2023 19:38

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

TRADING UPDATES: Braemar investigation to end; Marula reports delay

22nd Sep 2023 20:37

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday, Thursday and Wednesday and not separately reported by Alliance News: Read More

Allergy Therapeutics shares plunge on expected loss and revenue drop

10th Aug 2023 11:11

(Alliance News) - Allergy Therapeutics PLC on Thursday said it expects to swing to a loss for the full-year as revenue plummets on production disruptions. Read More

Allergy Therapeutics appoints new CFO; interim CFO to leave in August

10th Jul 2023 13:45

(Alliance News) - Allergy Therapeutics PLC on Monday said it has promoted Group Financial Controller Shaun Furlong to chief financial officer. Read More

Allergy Therapeutics banks on second half-year to boost revenue

19th Jun 2023 11:40

(Alliance News) - Allergy Therapeutics PLC on Monday said its loss widened and revenue fell, with costs going up as new research studies progress, but predicted improved sales in the second half of the year thanks to higher demand in the seasonal allergy market. Read More

Allergy Therapeutics enters GBP41 million facility with ZQ Capital

6th Apr 2023 14:42

(Alliance News) - Allergy Therapeutics PLC on Thursday said it has entered into a senior secured facility agreement with ZQ Capital Management Ltd, through its affiliate SkyGem International Holdings Ltd and Southern Fox Investments Ltd. Read More

TRADING UPDATES: Sabien works with Empiric; Coro sells in Italy

27th Mar 2023 18:42

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

Allergy Therapeutics revenue drops but optimistic about funding

20th Jan 2023 10:37

(Alliance News) - Allergy Therapeutics PLC on Friday said it expects a drop in revenue during the first half of its financial year, but it remains confident about funding opportunities. Read More

LONDON MARKET CLOSE: FTSE 100 edges higher and New York stocks jump

29th Dec 2022 16:52

(Alliance News) - London's FTSE 100 achieved a solid, though unspectacular, gain during the final full trading of the year on Thursday, with investors mindful of what an ease of Covid-19 curbs in China could mean for global inflation. Read More

LONDON MARKET MIDDAY: Covid concerns in China drag stocks lower

29th Dec 2022 12:14

(Alliance News) - Stock prices in London at midday continued to be weighed down by the worrying surge in Covid-19 cases as China swiftly re-opens from three years of strict lockdown measures. Read More

AIM WINNERS & LOSERS: Allergy Therapeutics plunges as results delayed

29th Dec 2022 09:26

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday. Read More

LONDON MARKET OPEN: Sea of red as investors fret over Covid in China

29th Dec 2022 08:50

(Alliance News) - Stock prices in London opened lower on Thursday amid risk-off sentiment across Europe, as concerns grew about rising Covid cases in China. Read More

Allergy Therapeutics shares halve as delayed audit to mean suspension

29th Dec 2022 08:22

Alliance News) - Allergy Therapeutics PLC on Thursday said it shares will be suspended next week, due to delays in completing the audit of its annual results. Read More

AIM WINNERS & LOSERS: Redcentric boasts "transformational" half-year

8th Dec 2022 11:07

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday. Read More

Allergy Therapeutics proffers peanut progress despite cost concerns

8th Dec 2022 11:04

(Alliance News) - Allergy Therapeutics PLC on Thursday saw shares drop despite the start of its peanut allergy testing trial, after it confirmed that cost control remains a preoccupation for management following a pause in production earlier in the year. Read More

Allergy Therapeutics hires interim CFO as Nick Wykeman steps down

21st Nov 2022 17:00

(Alliance News) - Allergy Therapeutics PLC on Monday said it appointed Martin Hopcroft as interim chief financial officer, as Nick Wykeman will step down at the end of November. Read More

AIM WINNERS & LOSERS: Directa Plus wins deal; Greatland loss widens

28th Oct 2022 11:33

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday. Read More

FTSE 100 Latest
Value10,223.54
Change51.78